Opinion
Video
Access Challenges Regarding the Use of Abiraterone in Patients With mCRPC
Author(s):
Panelists discuss how to address the challenges in providing optimal care for mCRPC patients and how barriers may vary between different healthcare settings, such as rural vs. urban and private vs. public.
Video Player is loading.
- mCRPC patients?
- How do you navigate these challenges to ensure patients receive optimal care?
- How might the barriers differ between various health care settings (eg, rural vs urban, private vs public)?
Related Videos
Study results affirm effectiveness of evolving prostate cancer therapies
Non–Muscle Invasive-Bladder Cancer Overview
NMIBC Maintenance Therapy: Timing, Dosing, and Follow-Up
BRCA Mutations in mHSPC: Impact on Therapy Selection
Formulations, Food, and Frequency: Optimizing Absorption and Tolerability in Daily Practice
Defining and Managing BCG-Unresponsive NMIBC
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Factors Contributing to Higher Incidence and Worse Outcomes of mHSPC in Black Men
The Incidence of Prostate Cancer and Risk of Progression in Black Men
The Biggest Challenges in Distinguishing ccRCC From Benign Renal Masses
Related Content
